New challenges to study heterogeneity in cancer redox metabolism

Frontiers in Cell and Developmental Biology

Volumn 5, Issue JUL, 2017, Pages

  Benfeitas, Rui ^a   Uhlen, Mathias ^a   Nielsen, Jens ^a,b   Mardinoglu, Adil ^a,b  

^a ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^b CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

Cancer heterogeneity; Personalized medicine; Reactive oxygen species; Redox biology; Systems biology

Indexed keywords

EID: 85026835225     PISSN: None     EISSN: 2296634X     Source Type: Journal    
DOI: 10.3389/fcell.2017.00065     Document Type: Review

References (273)

1. Agren, R., Bordel, S., Mardinoglu, A., Pornputtapong, N., Nookaew, I., and Nielsen, J. (2012). Reconstruction of genome-scale active metabolic networks for 69 human cell types and 16 cancer types using INIT. PLoS Comput. Biol. 8:e1002518. doi: 10.1371/journal.pcbi.1002518
2. Agren, R., Mardinoglu, A., Asplund, A., Kampf, C., Uhlen, M., and Nielsen, J. (2014). Identification of anticancer drugs for hepatocellular carcinoma through personalized genome-scale metabolic modeling. Mol. Syst. Biol. 10, 1-13. doi: 10.1002/msb.145122
3. Aran, D., Sirota, M., and Butte, A. J. (2015). Systematic pan-cancer analysis of tumour purity. Nat. Commun. 6:8971. doi: 10.1038/ncomms9971
4. Arnér, E. S. J., and Holmgren, A. (2006). The thioredoxin system in cancer. Semin. Cancer Biol. 16, 420-426. doi: 10.1016/j.semcancer.2006.10.009
5. Arnold, R. S., Shi, J., Murad, E., Whalen, A. M., Sun, C. Q., Polavarapu, R., et al. (2001). Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1. Proc. Natl. Acad. Sci. U.S.A. 98, 5550-5555. doi: 10.1073/pnas.101505898
6. Au, S. W. N., Gover, S., Lam, V. M. S., and Adams, M. J. (2000). Human glucose-6-phosphate dehydrogenase: the crystal structure reveals a structural NADP(+) molecule and provides insights into enzyme deficiency. Struct. Fold. Des. 8, 293-303. doi: 10.1016/S0969-2126(00)00104-0
7. Ayala, A., Muñoz, M. F., and Argüelles, S. (2014). Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid. Med. Cell. Longev. 2014:360438. doi: 10.1155/2014/360438
8. Babior, B. M., Lambeth, J. D., and Nauseef, W. (2002). The neutrophil NADPH oxidase. Arch. Biochem. Biophys. 397, 342-344. doi: 10.1006/abbi.2001.2642
9. Bannister, J. V., Bannister, W. H., Bray, R. C., Fielden, E. M., Roberts, P. B., and Rotilio, G. (1973). The superoxide dismutase activity of human erythrocuprein. FEBS Lett. 32, 303-306. doi: 10.1016/0014-5793(73)80859-2
10. Basu, A., Banerjee, H., Rojas, H., Martinez, S. R., Roy, S., Jia, Z., et al. (2011). Differential expression of peroxiredoxins in prostate cancer: consistent upregulation of PRDX3 and PRDX4. Prostate 71, 755-765. doi: 10.1002/pros.21292
11. Benfeitas, R., Selvaggio, G., Antunes, F., Coelho, P. M., and Salvador, A. (2014). Hydrogen peroxide metabolism and sensing in human erythrocytes: a validated kinetic model and reappraisal of the role of peroxiredoxin II. Free Radic. Biol. Med. 74, 35-49. doi: 10.1016/j.freeradbiomed.2014.06.007
12. Bielski, B. H., and Shiue, G. G. (1979). "Reaction rates of superoxide radicals with the essential aminoacids". in Oxygen Free Radicals and Tissue Damage, ed I. Fridovich (Amsterdam: Excerpta Medica), 43-56
13. Bienert, G. P., Møller, A. L. B., Kristiansen, K. A., Schulz, A., Møller, I. M., Schjoerring, J. K., et al. (2007). Specific aquaporins facilitate the diffusion of hydrogen peroxide across membranes. J. Biol. Chem. 282, 1183-1192. doi: 10.1074/jbc. M603761200
14. Bjornson, E., Boren, J., and Mardinoglu, A. (2016). Personalized cardiovascular disease prediction and treatment-a review of existing strategies and novel systems medicine tools. Front. Physiol. 7:2. doi: 10.3389/fphys.2016.00002
15. Bjornson, E., Mukhopadhyay, B., Asplund, A., Pristovsek, N., Cinar, R., Romeo, S., et al. (2015). Stratification of hepatocellular carcinoma patients based on acetate utilization. Cell Rep. 13, 2014-2026. doi: 10.1016/j.celrep.2015.10.045
16. Björnstedt, M., Xue, J., Huang, W., Åkesson, B., and Holmgren, A. (1994). The thioredoxin and glutaredoxin systems are efficient electron donors to human plasma glutathione peroxidase. J. Biol. Chem. 269, 29382-29384
17. Blot, W. J., Li, J.-Y. Y., Taylor, P. R., Guo, W., Dawsey, S., Wang, G.-Q., et al. (1993). Nutrition intervention trials in linxian, china: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J. Natl. Cancer Inst. 85, 1483-1492. doi: 10.1093/jnci/85.18.1483
18. Boros, L. G., Lee, P. W., Brandes, J. L., Cascante, M., Muscarella, P., Schirmer, W. J., et al. (1998). Nonoxidative pentose phosphate pathways and their direct role in ribose synthesis in tumors: is cancer a disease of cellular glucose metabolism? Med. Hypotheses 50, 55-59. doi: 10.1016/S0306-9877(98)90178-5
19. Boros, L. G., Puigjaner, J., Cascante, M., Lee, W. N. P., Brandes, J. L., Bassilian, S., et al. (1997). Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation. Cancer Res. 2, 4242-4248
20. Brown, G. C., and Borutaite, V. (2012). There is no evidence that mitochondria are the main source of reactive oxygen species in mammalian cells. Mitochondrion 12, 1-4. doi: 10.1016/j.mito.2011.02.001
21. Brune, B. (2005). The intimate relation between nitric oxide and superoxide in apoptosis and cell survival. Antioxid. Redox Signal. 7, 497-507. doi: 10.1089/ars.2005.7.497
22. Budihardjo, I. I., Walker, D. L., Svingen, P. A., Buckwalter, C. A., Desnoyers, S., Eckdahl, S., et al. (1998). 6-Aminonicotinamide sensitizes human tumor cell lines to cisplatin. Clin. Cancer Res. 4, 117-130
23. Buettner, G. R., Wagner, B. A., and Rodgers, V. G. J. (2013). Quantitative redox biology: an approach to understand the role of reactive species in defining the cellular redox environment. Cell Biochem. Biophys. 67, 477-483. doi: 10.1007/s12013-011-9320-3
24. Buxton, G. V., Greenstock, C. L., Helman, W. P., and Ross, A. B. (1988). Critical review of rate constants for reactions of hydrated electrons, hydrogen atoms and hydroxyl radicals (· OH/· O-) in aqueous solution. J. Phys. Chem. Ref. Data 17, 513-886. doi: 10.1063/1.555805
25. Bystrom, L. M., and Rivella, S. (2015). Cancer cells with irons in the fire. Free Radic. Biol. Med. 79, 337-342. doi: 10.1016/j.freeradbiomed.2014.04.035
26. Cadenas, C., Franckenstein, D., Schmidt, M., Gehrmann, M., Hermes, M., Geppert, B., et al. (2010). Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer. Breast Cancer Res. 12, R44. doi: 10.1186/bcr2599
27. Cairns, R. A., Harris, I. S., and Mak, T. W. (2011). Regulation of cancer cell metabolism. Nat. Rev. Cancer 11, 85-95. doi: 10.1038/nrc2981
28. Cao, J., Schulte, J., Knight, A., Leslie, N. R., Zagozdzon, A., Bronson, R., et al. (2009). Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity. EMBO J. 28, 1505-1517. doi: 10.1038/emboj.2009.101
29. Carlson, B. A., Tobe, R., Yefremova, E., Tsuji, P. A., Hoffmann, V. J., Schweizer, U., et al. (2016). Glutathione peroxidase 4 and vitamin E cooperatively prevent hepatocellular degeneration. Redox Biol. 9, 22-31. doi: 10.1016/j.redox.2016.05.003
30. Carlson, B. A., Yoo, M. H., Tobe, R., Mueller, C., Naranjo-Suarez, S., Hoffmann, V. J., et al. (2012). Thioredoxin reductase 1 protects against chemically induced hepatocarcinogenesis via control of cellular redox homeostasis. Carcinogenesis 33, 1806-1813. doi: 10.1093/carcin/bgs230
31. Chae, H. Z., Chung, S. J., and Rhee, S. G. (1994). Thioredoxin-dependent peroxide reductase from yeast. J. Biol. Chem. 269, 27670-27678
32. Chance, B., Sies, H., and Boveris, A. (1979). Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59, 527-605
33. Chang, T.-S., Jeong, W., Hyun, A. W., Sun, M. L., Park, S., Sue, G. R., et al. (2004). Characterization of mammalian sulfiredoxin and its reactivation of hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in the active site to cysteine. J. Biol. Chem. 279, 50994-51001. doi: 10.1074/jbc. M409482200
34. Chang, X. Z., Li, D. Q., Hou, Y. F., Wu, J., Lu, J. S., Di, G. H., et al. (2007). Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer. Breast Cancer Res. 9, R76. doi: 10.1186/bcr1789
35. Chen, K., Kirber, M. T., Xiao, H., Yang, Y., and Keaney, J. F. Jr. (2008). Regulation of ROS signal transduction by NADPH oxidase 4 localization. J. Cell Biol. 181, 1129-1139. doi: 10.1083/jcb.200709049
36. Chen, S. X., and Schopfer, P. (1999). Hydroxyl-radical production in physiological reactions. A novel function of peroxidase. Eur. J. Biochem. 260, 726-735. doi: 10.1046/j.1432-1327.1999.00199.x
37. Choe, Y., Yu, J., Son, Y., Park, S., Kim, J., Shi, X., et al. (2012). Continuously generated H2O2 stimulates the proliferation and osteoblastic differentiation of human periodontal ligament fibroblasts. J. Cell. Biochem. 113, 1426-1436. doi: 10.1002/jcb.24017
38. Chung-man Ho, J., Zheng, S., Comhair, S. A., Farver, C., and Erzurum, S. C. (2001). Differential expression of manganese superoxide dismutase and catalase in lung cancer. Cancer Res. 61, 8578-8585
39. Cooke, M. S., Evans, M. D., Dizdaroglu, M., and Lunec, J. (2003). Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J. 17, 1195-1214. doi: 10.1096/fj.02-0752rev
40. D'Autréaux, B., and Toledano, M. B. (2007). ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat. Rev. Mol. Cell Biol. 8, 813-824. doi: 10.1038/nrm2256
41. DeNicola, G. M., Karreth, F. A., Humpton, T. J., Gopinathan, A., Wei, C., Frese, K., et al. (2011). Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 475, 106-109. doi: 10.1038/nature10189
42. de Oliveira, V. A., da Motta, L. L., de Bastiani, M. A., Lopes, F. M., Müller, C. B., Gabiatti, B. P., et al. (2016). In vitro evaluation of antitumoral efficacy of catalase in combination with traditional chemotherapeutic drugs against human lung adenocarcinoma cells. Tumor Biol. 37, 10775-10784. doi: 10.1007/s13277-016-4973-6
43. De Preter, G., Neveu, M.-A., Danhier, P., Brisson, L., Payen, V. L., Porporato, P. E., et al. (2015). Inhibition of the pentose phosphate pathway by dichloroacetate unravels a missing link between aerobic glycolysis and cancer cell proliferation. Oncotarget 7, 2910-2920. doi: 10.18632/oncotarget.6272
44. Dhar, S. K., Tangpong, J., Chaiswing, L., Oberley, T. D., and Clair, D. K. S. (2011). Manganese superoxide dismutase is a p53-regulated gene that switches cancers between early and advanced stages. Cancer Res. 71, 6684-6695. doi: 10.1158/0008-5472.CAN-11-1233
45. Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., Kulp, A. N., et al. (2009). Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458, 780-783. doi: 10.1038/nature07733
46. Dikalov, S. (2011). Cross talk between mitochondria and NADPH oxidases. Free Radic. Biol. Med. 51, 1289-1301. doi: 10.1016/j.freeradbiomed.2011.06.033
47. Doskey, C. M., Buranasudja, V., Wagner, B. A., Wilkes, J. G., Du, J., Cullen, J. J., et al. (2016). Tumor cells have decreased ability to metabolize H2O2: implications for pharmacological ascorbate in cancer therapy. Redox Biol. 10, 274-284. doi: 10.1016/j.redox.2016.10.010
48. Du, M. Q., Carmichael, P. L., and Phillips, D. H. (1994). Induction of activating mutations in the human c-Ha-ras-1 proto-oncogene by oxygen free radicals. Mol. Carcinog. 11, 170-175. doi: 10.1002/mc.2940110308
49. Egler, R. A., Fernandes, E., Rothermund, K., Sereika, S., de Souza-Pinto, N., Jaruga, P., et al. (2005). Regulation of reactive oxygen species, DNA damage, and c-Myc function by peroxiredoxin 1. Oncogene 24, 8038-8050. doi: 10.1038/sj.onc.1208821
50. Elchuri, S., Oberley, T. D., Qi, W. B., Eisenstein, R. S., Roberts, L. J., Van Remmen, H., et al. (2005). CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene 24, 367-380. doi: 10.1038/sj.onc.1208207
51. Elsemman, I. E., Mardinoglu, A., Shoaie, S., Soliman, T. H., and Nielsen, J. (2016). Systems biology analysis of hepatitis C virus infection reveals the role of copy number increases in regions of chromosome 1q in hepatocellular carcinoma metabolism. Mol. Biosyst. 12, 1496-1506. doi: 10.1039/C5MB00827A
52. Esworthy, R. S., Chu, F. F., Geiger, P., Girotti, A. W., and Doroshow, J. H. (1993). Reactivity of plasma glutathione peroxidase with hydroperoxide substrates and glutathione. Arch. Biochem. Biophys. 307, 29-34. doi: 10.1006/abbi.1993.1555
53. Evans, J. L., Goldfine, I. D., Maddux, B. A., and Grodsky, G. M. (2002). Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr. Rev. 23, 599-622. doi: 10.1210/er.2001-0039
54. Fan, J., Ye, J., Kamphorst, J. J., Shlomi, T., Thompson, C. B., and Rabinowitz, J. D. (2014). Quantitative flux analysis reveals folate-dependent NADPH production. Nature 510, 298-302. doi: 10.1038/nature13236
55. Faratian, D., Goltsov, A., Lebedeva, G., Sorokin, A., Moodie, S., Mullen, P., et al. (2009). Systems biology reveals new strategies for personalizing cancer medicine and confirms the role of PTEN in resistance to trastuzumab. Cancer Res. 69, 6713-6720. doi: 10.1158/0008-5472.CAN-09-0777
56. Fenton, H. J. H. (1894). LXXIII.-Oxidation of tartaric acid in presence of iron. J. Chem. Soc. Trans. 65, 899-910. doi: 10.1039/CT8946500899
57. Finkel, T. (2011). Signal transduction by reactive oxygen species. J. Cell Biol. 194, 7-15. doi: 10.1083/jcb.201102095
58. Flint, D. H., Tuminello, J. F., and Emptage, M. H. (1993). The inactivation of Fe-S cluster containing hydro-lyases by superoxide. J. Biol. Chem. 268, 22369-22376
59. Forman, H. J., Maiorino, M., and Ursini, F. (2010). Signaling Functions of Reactive Oxygen Species. Biochemistry 49, 835-842. doi: 10.1021/bi9020378
60. Fransen, M., Nordgren, M., Wang, B., and Apanasets, O. (2012). Role of peroxisomes in ROS/RNS-metabolism: implications for human disease. Biochim. Biophys. Acta Mol. Basis Dis. 1822, 1363-1373. doi: 10.1016/j.bbadis.2011.12.001
61. Frohlich, D. A., McCabe, M. T., Arnold, R. S., and Day, M. L. (2008). The role of Nrf2 in increased reactive oxygen species and DNA damage in prostate tumorigenesis. Oncogene 27, 4353-4362. doi: 10.1038/onc.2008.79
62. Gaglio, D., Metallo, C. M., Gameiro, P. A., Hiller, K., Danna, L. S., Balestrieri, C., et al. (2011). Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth. Mol. Syst. Biol. 7, 523. doi: 10.1038/msb.2011.56
63. Galaris, D., Skiada, V., and Barbouti, A. (2008). Redox signaling and cancer: the role of "labile" iron. Cancer Lett. 266, 21-29. doi: 10.1016/j.canlet.2008.02.038
64. Gao, P., Zhang, H., Dinavahi, R., Li, F., Xiang, Y., Raman, V., et al. (2007). HIF-dependent antitumorigenic effect of antioxidants in vivo. Cancer Cell 12, 230-238. doi: 10.1016/j.ccr.2007.08.004
65. Gao, X., Liu, Y., Deeb, D., Liu, P., Liu, A., Arbab, A. S., et al. (2013). ROS mediate proapoptotic and antisurvival activity of oleanane triterpenoid CDDO-Me in ovarian cancer cells. Anticancer Res. 33, 215-221
66. Gardner, P. R., Raineri, I., Epstein, L. B., and White, C. W. (1995). Superoxide radical and iron modulate aconitase activity in mammalian cells. J. Biol. Chem. 270, 13399-13405. doi: 10.1074/jbc.270.22.13399
67. Garrison, W. (1987). Reaction mechanisms in the radiolysis of peptides, polypeptides, and proteins. Chem. Rev. 87, 381-398. doi: 10.1021/cr00078a006
68. Ghaffari, P., Mardinoglu, A., Asplund, A., Shoaie, S., Kampf, C., Uhlen, M., et al. (2015a). Identifying anti-growth factors for human cancer cell lines through genome-scale metabolic modeling. Sci. Rep. 5:8183. doi: 10.1038/srep08183
69. Ghaffari, P., Mardinoglu, A., and Nielsen, J. (2015b). Cancer metabolism: a modeling perspective. Front. Physiol. 6:382. doi: 10.3389/fphys.2015.00382
70. Giannoni, E., Buricchi, F., Raugei, G., Ramponi, G., and Chiarugi, P. (2005). Intracellular reactive oxygen species activate Src tyrosine kinase during cell adhesion and anchorage-dependent cell growth. Mol. Cell. Biol. 25, 6391-6403. doi: 10.1128/MCB.25.15.6391-6403.2005
71. Giusti, L., Iacconi, P., Ciregia, F., Giannaccini, G., Donatini, G. L., Basolo, F., et al. (2008). Fine-needle aspiration of thyroid nodules: proteomic analysis to identify cancer biomarkers. J. Proteome Res. 7, 4079-4088. doi: 10.1021/pr8000404
72. Glorieux, C., Dejeans, N., Sid, B., Beck, R., Calderon, P. B., and Verrax, J. (2011). Catalase overexpression in mammary cancer cells leads to a less aggressive phenotype and an altered response to chemotherapy. Biochem. Pharmacol. 82, 1384-1390. doi: 10.1016/j.bcp.2011.06.007
73. Glorieux, C., Zamocky, M., Sandoval, J. M., Verrax, J., and Calderon, P. B. (2015). Regulation of catalase expression in healthy and cancerous cells. Free Radic. Biol. Med. 87, 84-97. doi: 10.1016/j.freeradbiomed.2015.06.017
74. Goh, J., Enns, L., Fatemie, S., Hopkins, H., Morton, J., Pettan-Brewer, C., et al. (2011). Mitochondrial targeted catalase suppresses invasive breast cancer in mice. BMC Cancer 11:191. doi: 10.1186/1471-2407-11-191
75. Goncalves, K., Sullivan, K., and Phelan, S. (2012). Differential expression and function of peroxiredoxin 1 and peroxiredoxin 6 in cancerous MCF-7 and noncancerous MCF-10A breast epithelial cells. Cancer Invest. 30, 38-47. doi: 10.3109/07357907.2011.629382
76. Goodman, M., Bostick, R. M., Kucuk, O., and Jones, D. P. (2011). Clinical trials of antioxidants as cancer prevention agents: past, present, and future. Free Radic. Biol. Med. 51, 1068-1084. doi: 10.1016/j.freeradbiomed.2011.05.018
77. Gorrini, C., Harris, I. S., and Mak, T. W. (2013). Modulation of oxidative stress as an anticancer strategy. Nat. Rev. Drug Discov. 12, 931-947. doi: 10.1038/nrd4002
78. Gotoh, Y., and Cooper, J. A. (1998). Reactive oxygen species-and dimerization-induced activation of apoptosis signal-regulating kinase 1 in tumor necrosis factor-a signal transduction. J. Biol. Chem. 273, 17477-17482. doi: 10.1074/jbc.273.28.17477
79. Gupta, S. C., Hevia, D., Patchva, S., Park, B., Koh, W., and Aggarwal, B. B. (2012). Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy. Antioxid. Redox Signal. 16, 1295-1322. doi: 10.1089/ars.2011.4414
80. Hampton, M. B., Kettle, A. J., and Winterbourn, C. C. (1998). Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 92, 3007-3017
81. Hanczko, R., Fernandez, D. R., Doherty, E., Qian, Y., Vas, G., Niland, B., et al. (2009). Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteine. J. Clin. Invest. 119, 1546-1557. doi: 10.1172/JCI35722
82. Harris, I. S., Treloar, A. E., Inoue, S., Sasaki, M., Gorrini, C., Lee, K., et al. (2015). Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. Cancer Cell 27, 211-222. doi: 10.1016/j.ccell.2014.11.019
83. Hart, P. C., Mao, M., de Abreu, A. L. P., Ansenberger-Fricano, K., Ekoue, D. N., Ganini, D., et al. (2015). MnSOD upregulation sustains the Warburg effect via mitochondrial ROS and AMPK-dependent signalling in cancer. Nat. Commun. 6:6053. doi: 10.1038/ncomms7053
84. Havens, C. G., Ho, A., Yoshioka, N., and Dowdy, S. F. (2006). Regulation of late G1/S phase transition and APCCdh1 by reactive oxygen species. Mol. Cell. Biol. 26, 4701-4711. doi: 10.1128/MCB.00303-06
85. Hay, N. (2016). Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? Nat. Rev. Cancer 16, 635-649. doi: 10.1038/nrc.2016.77
86. Heinrich, P. C., Morris, H. P., and Weber, G. (1976). Behavior of transaldolase (EC 2.2.1.2) and transketolase (EC 2.2.1.1) activities in normal, neoplastic, differentiating, and regenerating liver. Cancer Res. 36, 3189-3197
87. Hempel, N., Carrico, P. M., and Melendez, J. A. (2011). Manganese superoxide dismutase (Sod2) and redox-control of signaling events that drive metastasis. Anticancer. Agents Med. Chem. 11, 191-201. doi: 10.2174/187152011795255911
88. Higinbotham, K. G., Rice, J. M., Kasprzak, K. S., Reed, C. D., and Perantoni, A. O. (1992). GGT to GTT transversions in codon 12 of the K-ras oncogene in rat renal sarcomas induced with nickel subsulfide or nickel subsulfide/iron are consistent with oxidative damage to DNA. Cancer Res. 52, 4747-4751
89. Hileman, E. O., Liu, J., Albitar, M., Keating, M. J., and Huang, P. (2004). Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity. Cancer Chemother. Pharmacol. 53, 209-219. doi: 10.1007/s00280-003-0726-5
90. Hofree, M., Shen, J. P., Carter, H., Gross, A., and Ideker, T. (2013). Network-based stratification of tumor mutations. Nat. Methods 10, 1108-1115. doi: 10.1038/nmeth.2651
91. Höhn, A., König, J., and Grune, T. (2013). Protein oxidation in aging and the removal of oxidized proteins. J. Proteomics 92, 132-159. doi: 10.1016/j.jprot.2013.01.004
92. Holley, A. K., Dhar, S. K., Xu, Y., and Clair, D. K. S. (2012). Manganese superoxide dismutase: beyond life and death. Amino Acids 42, 139-158. doi: 10.1007/s00726-010-0600-9
93. Hornsveld, M., and Dansen, T. B. (2016). The hallmarks of cancer from a redox perspective. Antioxid. Redox Signal. 25, 300-325. doi: 10.1089/ars.2015.6580
94. Hu, Y., Rosen, D. G., Zhou, Y., Feng, L., Yang, G., Liu, J., et al. (2005). Mitochondrial manganese-superoxide dismutase expression in ovarian cancer: role in cell proliferation and response to oxidative stress. J. Biol. Chem. 280, 39485-39492. doi: 10.1074/jbc. M503296200
95. Huang, P., Feng, L., Oldham, E. A., Keating, M. J., and Plunkett, W. (2000). Superoxide dismutase as a target for the selective killing of cancer cells. Nature 407, 390-395. doi: 10.1038/35030140
96. Huie, R. E., and Padmaja, S. (1993). The reaction of NO with superoxide. Free Radic. Res. 18, 195-199. doi: 10.3109/10715769309145868
97. Hyötyläinen, T., Jerby, L., Petäjä, E. M., Mattila, I., Jäntti, S., Auvinen, P., et al. (2016). Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease. Nat. Commun. 7:8994. doi: 10.1038/ncomms9994
98. Ishikawa, K., Takenaga, K., Akimoto, M., Koshikawa, N., Yamaguchi, A., Imanishi, H., et al. (2008). ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 320, 661-664. doi: 10.1126/science.1156906
99. Janssen, A. M. L., Bosman, C. B., Kruidenier, L., Griffioen, G., Lamers, C., Van Krieken, J., et al. (1999). Superoxide dismutases in the human colorectal cancer sequence. J. Cancer Res. Clin. Oncol. 125, 327-335. doi: 10.1007/s004320050282
100. Jarvis, R. M., Hughes, S. M., and Ledgerwood, E. C. (2012). Peroxiredoxin 1 functions as a signal peroxidase to receive, transduce, and transmit peroxide signals in mammalian cells. Free Radic. Biol. Med. 53, 1522-1530. doi: 10.1016/j.freeradbiomed.2012.08.001
101. Jeng, W., Loniewska, M. M., and Wells, P. G. (2013). Brain glucose-6-phosphate dehydrogenase protects against endogenous oxidative DNA damage and neurodegeneration in aged mice. ACS Chem. Neurosci. 4, 1123-1132. doi: 10.1021/cn400079y
102. Jerby, L., and Ruppin, E. (2012). Predicting drug targets and biomarkers of cancer via genome-scale metabolic modeling. Clin. Cancer Res. 18, 5572-5584. doi: 10.1158/1078-0432.CCR-12-1856
103. Jiang, P., Du, W., Mancuso, A., Wellen, K. E., and Yang, X. (2013). Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence. Nature 493, 689-693. doi: 10.1038/nature11776
104. Johansson, C., Lillig, C. H., and Holmgren, A. (2004). Human mitochondrial glutaredoxin reduces S-glutathionylated proteins with high affinity accepting electrons from either glutathione or thioredoxin reductase. J. Biol. Chem. 279, 7537-7543. doi: 10.1074/jbc. M312719200
105. Johnson, R. M., Goyette, G., Ravindranath, Y., and Ho, Y.-S. S. (2005). Hemoglobin autoxidation and regulation of endogenous H2O2 levels in erythrocytes. Free Radic. Biol. Med. 39, 1407-1417. doi: 10.1016/j.freeradbiomed.2005.07.002
106. Jonas, S. K., Benedetto, C., Flatman, A., Hammond, R. H., Micheletti, L., Riley, C., et al. (1992). Increased activity of 6-phosphogluconate dehydrogenase and glucose-6-phosphate dehydrogenase in purified cell suspensions and single cells from the uterine cervix in cervical intraepithelial neoplasia. Br. J. Cancer 66, 185-191. doi: 10.1038/bjc.1992.240
107. Jones, D. P. (2006). Disruption of mitochondrial redox circuitry in oxidative stress. Chem. Biol. Interact. 163, 38-53. doi: 10.1016/j.cbi.2006.07.008
108. Juarez, J. C., Manuia, M., Burnett, M., Betancourt, O., Boivin, B., Shaw, D. E., et al. (2008). Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation and inactivation of phosphatases in growth factor signaling. Proc. Natl. Acad. Sci. U.S.A. 105, 7147-7152. doi: 10.1073/pnas.0709451105
109. Kaewpila, S., Venkataraman, S., Buettner, G. R., and Oberley, L. W. (2008). Manganese superoxide dismutase modulates hypoxia-inducible factor-1 alpha induction via superoxide. Cancer Res. 68, 2781-2788. doi: 10.1158/0008-5472.CAN-07-2635
110. Kaimul, A. M., Nakamura, H., Masutani, H., and Yodoi, J. (2007). Thioredoxin and thioredoxin-binding protein-2 in cancer and metabolic syndrome. Free Radic. Biol. Med. 43, 861-868. doi: 10.1016/j.freeradbiomed.2007.05.032
111. Kampf, C., Mardinoglu, A., Fagerberg, L., Hallström, B. M., Danielsson, A., Nielsen, J., et al. (2014a). Defining the human gallbladder proteome by transcriptomics and affinity proteomics. Proteomics 14, 2498-2507. doi: 10.1002/pmic.201400201
112. Kampf, C., Mardinoglu, A., Fagerberg, L., Hallström, B. M., Edlund, K., Lundberg, E., et al. (2014b). The human liver-specific proteome defined by transcriptomics and antibody-based profiling. FASEB J. 28, 1-14. doi: 10.1096/fj.14-250555
113. Kasiappan, R., and Safe, S. (2016). ROS-inducing agents for cancer chemotherapy. React. Oxyg. Species 1, 22-37. doi: 10.20455/ros.2016.805
114. Klein, E. A., Thompson, I. M. Jr., Tangen, C. M., John, J., Lucia, M. S., Goodman, P. J., et al. (2011). Vitamin E and the risk of prostate cancer: updated results of the selenium and vitamin E cancer prevention trial (SELECT). J. Am. Med. Assoc. 306, 1549-1556. doi: 10.1001/jama.2011.1437
115. Kondo, S., Toyokuni, S., Iwasa, Y., Tanaka, T., Onodera, H., Hiai, H., et al. (1999). Persistent oxidative stress in human colorectal carcinoma, but not in adenoma. Free Radic. Biol. Med. 27, 401-410. doi: 10.1016/S0891-5849(99)00087-8
116. Koppenol, W. H. (2001). The Haber-Weiss cycle-70 years later. Redox Rep. 6, 229-234. doi: 10.1179/135100001101536373
117. Kowaltowski, A. J., de Souza-Pinto, N. C., Castilho, R. F., and Vercesi, A. E. (2009). Mitochondria and reactive oxygen species. Free Radic. Biol. Med. 47, 333-343. doi: 10.1016/j.freeradbiomed.2009.05.004
118. Labunskyy, V. M., and Gladyshev, V. N. (2013). Role of reactive oxygen species-mediated signaling in aging. Antioxid. Redox Signal. 19, 1362-1372. doi: 10.1089/ars.2012.4891
119. LaButti, J. N., Chowdhury, G., Reilly, T. J., and Gates, K. S. (2007). Redox regulation of protein tyrosine phosphatase 1B by peroxymonophosphate (O3POOH). J. Am. Chem. Soc. 129, 5320-5321. doi: 10.1021/ja070194j
120. Latimer, H. R., and Veal, E. A. (2016). Peroxiredoxins in regulation of MAPK signalling pathways; sensors and barriers to signal transduction. Mol. Cells 39, 40-45. doi: 10.14348/molcells.2016.2327
121. Lee, K. W., Lee, D. J., Lee, J. Y., Kang, D. H., Kwon, J., and Kang, S. W. (2011). Peroxiredoxin II restrains DNA damage-induced death in cancer cells by positively regulating JNK-dependent DNA repair. J. Biol. Chem. 286, 8394-8404. doi: 10.1074/jbc. M110.179416
122. Lee, S., Zhang, C., Kilicarslan, M., Piening, B. D. D., Bjornson, E., Hallström, B. M. M., et al. (2016). integrated network analysis reveals an association between plasma mannose levels and insulin resistance. Cell Metab. 24, 1-13. doi: 10.1016/j.cmet.2016.05.026
123. Leiserson, M. D. M., Vandin, F., Wu, H.-T., Dobson, J. R., Eldridge, J. V., Thomas, J. L., et al. (2014). Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes. Nat. Genet. 47, 106-114. doi: 10.1038/ng.3168
124. Li, L., Shoji, W., Oshima, H., Obinata, M., Fukumoto, M., and Kanno, N. (2008). Crucial role of peroxiredoxin III in placental antioxidant defense of mice. FEBS Lett. 582, 2431-2434. doi: 10.1016/j.febslet.2008.05.050
125. Li, L., and Yu, A. Q. (2015). The functional role of peroxiredoxin 3 in reactive oxygen species, apoptosis, and chemoresistance of cancer cells. J. Cancer Res. Clin. Oncol. 141, 2071-2077. doi: 10.1007/s00432-015-1916-3
126. Li, L., Zhang, Y. G., and Chen, C. L. (2013). Anti-apoptotic role of peroxiredoxin III in cervical cancer cells. FEBS Open Bio. 3, 51-54. doi: 10.1016/j.fob.2012.12.002
127. Lien, E. C., Lyssiotis, C. A., Juvekar, A., Hu, H., Asara, J. M., Cantley, L. C., et al. (2016). Glutathione biosynthesis is a metabolic vulnerability in PI(3)K/Akt-driven breast cancer. Nat. Cell Biol. 18, 572-578. doi: 10.1038/ncb3341
128. Lin, R., Elf, S., Shan, C., Kang, H.-B., Ji, Q., Zhou, L., et al. (2015). 6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling. Nat. Cell Biol. 17, 1484-1496. doi: 10.1038/ncb3255
129. Lincoln, D. T., Ali Emadi, E. M., Tonissen, K. F., and Clarke, F. M. (2003). The thioredoxin-thioredoxin reductase system: over-expression in human cancer. Anticancer Res. 23, 2425-2433
130. Lindskog, C., Linné, J., Fagerberg, L., Hallström, B. M., Sundberg, C. J., Lindholm, M., et al. (2015). The human cardiac and skeletal muscle proteomes defined by transcriptomics and antibody-based profiling. BMC Genomics 16:475. doi: 10.1186/s12864-015-1686-y
131. Little, C., and O'brien, P. J. (1969). Mechanism of peroxide-inactivation of the sulphydryl enzyme glyceraldehyde-3-phosphate dehydrogenase. Eur. J. Biochem. 10, 533-538
132. Liu, H., Huang, D., McArthur, D. L., Boros, L. G., Nissen, N., and Heaney, A. P. (2010). Fructose induces transketolase flux to promote pancreatic cancer growth. Cancer Res. 70, 6368-6376. doi: 10.1158/0008-5472.CAN-09-4615
133. Liu, Z., Li, S., Cai, Y., Wang, A., He, Q., Zheng, C., et al. (2012). Manganese superoxide dismutase induces migration and invasion of tongue squamous cell carcinoma via H2O2-dependent Snail signaling. Free Radic. Biol. Med. 53, 44-50. doi: 10.1016/j.freeradbiomed.2012.04.031
134. Low, F. M., Hampton, M. B., Peskin, A. V., and Winterbourn, C. C. (2007). Peroxiredoxin 2 functions as a noncatalytic scavenger of low-level hydrogen peroxide in the erythrocyte. Blood 109, 2611-2617. doi: 10.1182/blood-2006-09-048728
135. Lu, H., Samanta, D., Xiang, L., Zhang, H., Hu, H., Chen, I., et al. (2015). Chemotherapy triggers HIF-1-dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype. Proc. Natl. Acad. Sci. U.S.A. 112, E4600-E4609. doi: 10.1073/pnas.1513433112
136. Lu, P., Vogel, C., Wang, R., Yao, X., and Marcotte, E. M. (2007). Absolute protein expression profiling estimates the relative contributions of transcriptional and translational regulation. Nat. Biotechnol. 25, 117-124. doi: 10.1038/nbt1270
137. Lu, W., Fu, Z., Wang, H., Feng, J., Wei, J., and Guo, J. (2014). Peroxiredoxin 2 is upregulated in colorectal cancer and contributes to colorectal cancer cells' survival by protecting cells from oxidative stress. Mol. Cell. Biochem. 387, 261-270. doi: 10.1007/s11010-013-1891-4
138. Lu, Y. P., Lou, Y. R., Yen, P., Newmark, H. L., Mirochnitchenko, O. I., Inouye, M., et al. (1997). Enhanced skin carcinogenesis in transgenic mice with high expression of glutathione peroxidase or both glutathione peroxidase and superoxide dismutase. Cancer Res. 57, 1468-1474
139. Maiti, A. K. (2010). Gene network analysis of oxidative stress-mediated drug sensitivity in resistant ovarian carcinoma cells. Pharmacogenomics J. 10, 94-104. doi: 10.1038/tpj.2009.49
140. Mandal, P. K., Seiler, A., Perisic, T., Kölle, P., Canak, A. B., Förster, H., et al. (2010). System xc-and thioredoxin reductase 1 cooperatively rescue glutathione deficiency. J. Biol. Chem. 285, 22244-22253. doi: 10.1074/jbc. M110.121327
141. Manta, B., Hugo, M., Ortiz, C., Ferrer-Sueta, G., Trujillo, M., and Denicola, A. (2009). The peroxidase and peroxynitrite reductase activity of human erythrocyte peroxiredoxin 2. Arch. Biochem. Biophys. 484, 146-154. doi: 10.1016/j.abb.2008.11.017
142. Marchissio, M. J., Frances, D. E., Carnovale, C. E., and Marinelli, R. A. (2012). Mitochondrial aquaporin-8 knockdown in human hepatoma HepG2 cells causes ROS-induced mitochondrial depolarization and loss of viability. Toxicol. Appl. Pharmacol. 264, 246-254. doi: 10.1016/j.taap.2012.08.005
143. Mardinoglu, A., Agren, R., Kampf, C., Asplund, A., Nookaew, I., Jacobson, P., et al. (2013a). Integration of clinical data with a genome-scale metabolic model of the human adipocyte. Mol. Syst. Biol. 9:649. doi: 10.1038/msb.2013.5
144. Mardinoglu, A., Agren, R., Kampf, C., Asplund, A., Uhlen, M., and Nielsen, J. (2014a). Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease. Nat. Commun. 5:3083. doi: 10.1038/ncomms4083
145. Mardinoglu, A., Bjornson, E., Zhang, C., Klevstig, M., Söderlund, S., Ståhlman, M., et al. (2017). Personal model-assisted identification of NAD+ and glutathione metabolism as intervention target in NAFLD. Mol. Syst. Biol. 13, 1-17. doi: 10.15252/msb.20167422
146. Mardinoglu, A., Boren, J., Ulf, S., Uhlén, M., and Nielsen, J. (in press). The employment of systems biology in gastroenterology hepatology. Nat. Rev. Gastroenterol. Hepatol
147. Mardinoglu, A., Gatto, F., and Nielsen, J. (2013b). Genome-scale modeling of human metabolism-a systems biology approach. Biotechnol. J. 8, 985-996. doi: 10.1002/biot.201200275
148. Mardinoglu, A., Heiker, J. T., Gärtner, D., Björnson, E., Schön, M. R., Flehmig, G., et al. (2015a). Extensive weight loss reveals distinct gene expression changes in human subcutaneous and visceral adipose tissue. Sci. Rep. 5:14841. doi: 10.1038/srep14841
149. Mardinoglu, A., Kampf, C., Asplund, A., Fagerberg, L., Hallström, B. M., Edlund, K., et al. (2014b). Defining the human adipose tissue proteome to reveal metabolic alterations in obesity. J. Proteome Res. 13, 5106-5119. doi: 10.1021/pr500586e
150. Mardinoglu, A., and Nielsen, J. (2012). Systems medicine and metabolic modelling. J. Intern. Med. 271, 142-154. doi: 10.1111/j.1365-2796.2011.02493.x
151. Mardinoglu, A., and Nielsen, J. (2015). New paradigms for metabolic modeling of human cells. Curr. Opin. Biotechnol. 34, 91-97. doi: 10.1016/j.copbio.2014.12.013
152. Mardinoglu, A., and Nielsen, J. (2016). Editorial: the impact of systems medicine on human health and disease. Front. Physiol. 7:552. doi: 10.3389/fphys.2016.00552
153. Mardinoglu, A., Shoaie, S., Bergentall, M., Ghaffari, P., Zhang, C., Larsson, E., et al. (2015b). The gut microbiota modulates host amino acid and glutathione metabolism in mice. Mol. Syst. Biol. 11:834. doi: 10.15252/msb.20156487
154. Mardinoglu, A., and Uhlén, M. (2016). Liver: phenotypic and genetic variance: a systems approach to the liver. Nat. Rev. Gastroenterol. Hepatol. 13, 439-440. doi: 10.1038/nrgastro.2016.93
155. Marinho, H. S., Real, C., Cyrne, L., Soares, H., and Antunes, F. (2014). Hydrogen peroxide sensing, signaling and regulation of transcription factors. Redox Biol. 2, 535-562. doi: 10.1016/j.redox.2014.02.006
156. Mazurek, S., Boschek, C. B., Hugo, F., and Eigenbrodt, E. (2005). Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin. Cancer Biol. 15, 300-308. doi: 10.1016/j.semcancer.2005.04.009
157. Mehrmohamadi, M., Liu, X., Shestov, A. A., and Locasale, J. W. (2014). Characterization of the usage of the serine metabolic network in human cancer. Cell Rep. 9, 1507-1519. doi: 10.1016/j.celrep.2014.10.026
158. Menon, S. G., and Goswami, P. C. (2007). A redox cycle within the cell cycle: ring in the old with the new. Oncogene 26, 1101-1109. doi: 10.1038/sj.onc.1209895
159. Messner, K. R., and Imlay, J. A. (2002). Mechanism of superoxide and hydrogen peroxide formation by fumarate reductase, succinate dehydrogenase, and aspartate oxidase. J. Biol. Chem. 277, 42563-42571. doi: 10.1074/jbc. M204958200
160. Miar, A., Hevia, D., Muñoz-Cimadevilla, H., Astudillo, A., Velasco, J., Sainz, R. M., et al. (2015). Manganese superoxide dismutase (SOD2/MnSOD)/catalase and SOD2/GPx1 ratios as biomarkers for tumor progression and metastasis in prostate, colon, and lung cancer. Free Radic. Biol. Med. 85, 45-55. doi: 10.1016/j.freeradbiomed.2015.04.001
161. Miranda, A., Janssen, L., Bosman, C. B., van Duijn, W., Oostendorp-van de Ruit, M. M., Kubben, F. J., et al. (2000). Superoxide dismutases in gastric and esophageal cancer and the prognostic impact in gastric cancer. Clin. Cancer Res. 6, 3183-3192
162. Mohr, S., Hallak, H., de Boitte, A., Lapetina, E. G., and Brune, B. (1999). Nitric oxide-induced S-glutathionylation and inactivation of glyceraldehyde-3-phosphate dehydrogenase. J. Biol. Chem. 274, 9427-9430. doi: 10.1074/jbc.274.14.9427
163. Morinaka, A., Funato, Y., Uesugi, K., and Miki, H. (2011). Oligomeric peroxiredoxin-I is an essential intermediate for p53 to activate MST1 kinase and apoptosis. Oncogene 30, 4208-4218. doi: 10.1038/onc.2011.139
164. Murawaki, Y. Y., Tsuchiya, H., Kanbe, T., Harada, K., Yashima, K., Nozaka, K., et al. (2008). Aberrant expression of selenoproteins in the progression of colorectal cancer. Cancer Lett. 259, 218-230. doi: 10.1016/j.canlet.2007.10.019
165. Murphy, M. P. (2009). How mitochondria produce reactive oxygen species. Biochem. J. 417, 1-13. doi: 10.1042/BJ20081386
166. Nagy, P., and Winterbourn, C. C. (2010). Redox chemistry of biological thiols. Adv. Mol. Toxicol. 4, 183-222. doi: 10.1016/S1872-0854(10)04006-3
167. Naticchia, M. R., Brown, H. A., Garcia, F. J., Lamade, A. M., Justice, S. L., Herrin, R. P., et al. (2013). Bifunctional electrophiles cross-link thioredoxins with redox relay partners in cells. Chem. Res. Toxicol. 26, 490-497. doi: 10.1021/tx4000123
168. Nauseef, W. M. (2008). Biological roles for the NOX family NADPH oxidases. J. Biol. Chem. 283, 16961-16965. doi: 10.1074/jbc. R700045200
169. Nelson, K. K., Ranganathan, A. C., Mansouri, J., Rodriguez, A. M., Providence, K. M., Rutter, J. L., et al. (2003). Elevated Sod2 activity augments matrix metalloproteinase expression: evidence for the involvement of endogenous hydrogen peroxide in regulating metastasis. Clin. Cancer Res. 9, 424-432
170. Netto, L. E. S., and Antunes, F. (2016). The roles of peroxiredoxin and thioredoxin in hydrogen peroxide sensing and in signal transduction. Mol. Cells 39, 65-71. doi: 10.14348/molcells.2016.2349
171. Neumann, C. A., and Fang, Q. (2007). Are peroxiredoxins tumor suppressors? Curr. Opin. Pharmacol. 7, 375-380. doi: 10.1016/j.coph.2007.04.007
172. Nielsen, J. (2017). Systems biology of metabolism: a driver for developing personalized and precision medicine. Cell Metab. 25, 572-579. doi: 10.1016/j.cmet.2017.02.002
173. Nóbrega-pereira, S., Fernandez-marcos, P. J., Brioche, T., Gomez-cabrera, M. C., Salvador, A., Flores, J. M., et al. (2016). G6PD protects from oxidative damage and improves healthspan in mice. Nat. Commun. 7, 1-9. doi: 10.1038/ncomms10894
174. Oberley, T. D., and Oberley, L. W. (1997). Antioxidant enzyme levels in cancer. Histol. Histopathol. 12, 525-535
175. Oltra, A. M., Carbonell, F., Tormos, C., Iradi, A., and Sáez, G. T. (2001). Antioxidant enzyme activities and the production of MDA and 8-oxo-dG in chronic lymphocytic leukemia. Free Radic. Biol. Med. 30, 1286-1292. doi: 10.1016/S0891-5849(01)00521-4
176. Omenn, G., Goodman, G., Thornquist, M., Balmes, J., Cullen, M., and Glass, A. (1996). Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. New Engl. J. Med. 334, 1150-1155. doi: 10.1056/NEJM199605023341802
177. Pandolfi, P. P., Sonati, F., Rivi, R., Mason, P., Grosveld, F., and Luzzatto, L. (1995). Targeted disruption of the housekeeping gene encoding glucose 6-phosphate dehydrogenase (G6PD): G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress. EMBO J. 14, 5209-5215
178. Park, J. H., Kim, Y. S., Lee, H. L., Shim, J. Y., Lee, K. S., Oh, Y. J., et al. (2006). Expression of peroxiredoxin and thioredoxin in human lung cancer and paired normal lung. Respirology 11, 269-275. doi: 10.1111/j.1440-1843.2006.00849.x
179. Park, S. Y., Yu, X., Ip, C., Mohler, J. L., Bogner, P. N., and Park, Y. M. (2007). Peroxiredoxin 1 interacts with androgen receptor and enhances its transactivation. Cancer Res. 67, 9294-9303. doi: 10.1158/0008-5472.CAN-07-0651
180. Passos, J. F., Nelson, G., Wang, C., Richter, T., Simillion, C., Proctor, C. J., et al. (2010). Feedback between p21 and reactive oxygen production is necessary for cell senescence. Mol. Syst. Biol. 6:347. doi: 10.1038/msb.2010.5
181. Patra, K. C., and Hay, N. (2014). The pentose phosphate pathway and cancer. Trends Biochem. Sci. 39, 347-354. doi: 10.1016/j.tibs.2014.06.005
182. Paulsen, C. E., Truong, T. H., Garcia, F. J., Homann, A., Gupta, V., Leonard, S. E., et al. (2012). Peroxide-dependent sulfenylation of the EGFR catalytic site enhances kinase activity. Nat. Chem. Biol. 8, 57-64. doi: 10.1038/nchembio.736
183. Pawson, T., and Linding, R. (2008). Network medicine. FEBS Lett. 582, 1266-1270. doi: 10.1016/j.febslet.2008.02.011
184. Peng, L., Bian, X. W., Li, D. K., Xu, C., Wang, G. M., Xia, Q. Y., et al. (2015). Large-scale RNA-Seq transcriptome analysis of 4043 cancers and 548 normal tissue controls across 12 TCGA cancer types. Sci. Rep. 5:13413. doi: 10.1038/srep13413
185. Perkins, A., Poole, L. B., and Karplus, P. A. (2014). Tuning of peroxiredoxin catalysis for various physiological roles. Biochemistry 53, 7693-7705. doi: 10.1021/bi5013222
186. Peskin, A. V., Low, F. M., Paton, L. N., Maghzal, G. J., Hampton, M. B., and Winterbourn, C. C. (2007). The high reactivity of peroxiredoxin 2 with H2O2 is not reflected in its reaction with other oxidants and thiol reagents. J. Biol. Chem. 282, 11885-11892. doi: 10.1074/jbc. M700339200
187. Peskin, A. V., Pace, P. E., Behring, J. B., Paton, L. N., Soethoudt, M., Bachschmid, M. M., et al. (2016). Glutathionylation of the active site cysteines of peroxiredoxin 2 and recycling by glutaredoxin. J. Biol. Chem. 291, 3053-3062. doi: 10.1074/jbc. M115.692798
188. Piskounova, E., Agathocleous, M., Murphy, M. M., Hu, Z., Huddlestun, S. E., Zhao, Z., et al. (2015). Oxidative stress inhibits distant metastasis by human melanoma cells. Nature 527, 186-191. doi: 10.1038/nature15726
189. Pryor, W. A. (1986). Oxy-radicals and related species: their formation, lifetimes, and reactions. Annu. Rev. Physiol. 48, 657-667. doi: 10.1146/annurev.ph.48.030186.003301
190. Rabilloud, T., Heller, M., Rigobello, M. P., Bindoli, A., Aebersold, R., and Lunardi, J. (2001). The mitochondrial antioxidant defence system and its response to oxidative stress. Proteomics 1, 1105-1110. doi: 10.1002/1615-9861(200109)1:9<1105::AID-PROT1105>3.0.CO;2-M
191. Raïs, B., Comin, B., Puigjaner, J., Brandes, J. L., Creppy, E., Saboureau, D., et al. (1999). Oxythiamine and dehydroepiandrosterone induce a G1 phase cycle arrest in Ehrlich's tumor cells through inhibition of the pentose cycle. FEBS Lett. 456, 113-118. doi: 10.1016/S0014-5793(99)00924-2
192. Ray, G., Batra, S., Shukla, N. K., Deo, S., Raina, V., Ashok, S., et al. (2000). Lipid peroxidation, free radical production and antioxidant status in breast cancer. Breast Cancer Res. Treat. 59, 163-170. doi: 10.1023/A:1006357330486
193. Ray, P. D., Huang, B. W., and Tsuji, Y. (2012). Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell. Signal. 24, 981-990. doi: 10.1016/j.cellsig.2012.01.008
194. Reuter, S., Gupta, S. C., Chaturvedi, M. M., and Aggarwal, B. B. (2010). Oxidative stress, inflammation, and cancer: how are they linked? Free Radic. Biol. Med. 49, 1603-1616. doi: 10.1016/j.freeradbiomed.2010.09.006
195. Rigoulet, M., Yoboue, E. D., and Devin, A. (2011). Mitochondrial ROS generation and its regulation: mechanisms involved in H2O2 signaling. Antioxid. Redox Signal. 14, 459-468. doi: 10.1089/ars.2010.3363
196. Robbins, D., Wittwer, J. A., Codarin, S., Circu, M. L., Aw, T. Y., Huang, T. T., et al. (2012). Isocitrate dehydrogenase 1 is downregulated during early skin tumorigenesis which can be inhibited by overexpression of manganese superoxide dismutase. Cancer Sci. 103, 1429-1433. doi: 10.1111/j.1349-7006.2012.02317.x
197. Rodman, S. N., Spence, J. M., Ronnfeldt, T. J., Zhu, Y., Solst, S. R., O'Neill, R. A., et al. (2016). Enhancement of radiation response in breast cancer stem cells by inhibition of thioredoxin-and glutathione-dependent metabolism. Radiat. Res. 186, 385-395. doi: 10.1667/RR14463.1
198. Roh, J.-L., Jang, H. J., Kim, E. H., and Shin, D. (2016). Targeting of the glutathione, thioredoxin, and Nrf2 antioxidant systems in head and neck cancer. Antioxid. Redox Signal. 27, 106-114. doi: 10.1089/ars.2016.6841
199. Roots, R., and Okada, S. (1975). Estimation of life times and diffusion distances of radicals involved in x-ray-induced DNA strand breaks of killing of mammalian cells. Radiat. Res. 64, 306-320. doi: 10.2307/3574267
200. Rouault, T. A., and Klausner, R. D. (1996). Iron-sulfur clusters as biosensors of oxidants and iron. Trends Biochem. Sci. 21, 174-177. doi: 10.1016/S0968-0004(96)10024-4
201. Sabharwal, S. S., and Schumacker, P. T. (2014). Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel? Nat. Rev. Cancer 14, 709-721. doi: 10.1038/nrc3803
202. Saitoh, M., Nishitoh, H., Fujii, M., Takeda, K., Tobiume, K., Sawada, Y., et al. (1998). Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 17, 2596-2606. doi: 10.1093/emboj/17.9.2596
203. Sarsour, E. H., Kalen, A. L., and Goswami, P. C. (2014). Manganese superoxide dismutase regulates a redox cycle within the cell cycle. Antioxid. Redox Signal. 20, 1618-1627. doi: 10.1089/ars.2013.5303
204. Sayin, V. I., Ibrahim, M. X., Larsson, E., Nilsson, J. A., Lindahl, P., and Bergo, M. O. (2014). Antioxidants accelerate lung cancer progression in mice. Sci. Transl. Med. 6:221ra15. doi: 10.1126/scitranslmed.3007653
205. Schork, N. J. (2015). Personalized medicine: time for one-person trials. Nature 520, 609-611. doi: 10.1038/520609a
206. Sena, L. A., and Chandel, N. S. (2012). Physiological roles of mitochondrial reactive oxygen species. Mol. Cell 48, 158-166. doi: 10.1016/j.molcel.2012.09.025
207. Shan, C., Elf, S., Ji, Q., Kang, H. B., Zhou, L., Hitosugi, T., et al. (2014). Lysine acetylation activates 6-phosphogluconate dehydrogenase to promote tumor growth. Mol. Cell 55, 552-565. doi: 10.1016/j.molcel.2014.06.020
208. Sharma, V. K., and Rokita, S. E. (2013). Oxidation of Amino Acids, Peptides, and Proteins: Kinetics and Mechanism. Hoboken, NJ: John Wiley and Sons, Inc
209. Shen, X., Burguillos, M. A., Osman, A. M., Frijhoff, J., Carrillo-Jiménez, A., Kanatani, S., et al. (2016). Glioma-induced inhibition of caspase-3 in microglia promotes a tumor-supportive phenotype. Nat. Immunol. 17, 1282-1290. doi: 10.1038/ni.3545
210. Shibutani, S., Takeshita, M., and Grollman, A. P. (1991). Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature 349, 431-434. doi: 10.1038/349431a0
211. Skrzydlewska, E., Sulkowski, S., Koda, M., Zalewski, B., Kanczuga-Koda, L., and Sulkowska, M. (2005). Lipid peroxidation and antioxidant status in colorectal cancer. World J. Gastroenterol. 11, 403-406. doi: 10.3748/wjg.v11.i3.403
212. Smith, W. L., and Murphy, R. C. (2008). Oxidized lipids formed non-enzymatically by reactive oxygen species. J. Biol. Chem. 283, 15513-15514. doi: 10.1074/jbc. R800006200
213. Sobhakumari, A., Love-Homan, L., Fletcher, E. V. M., Martin, S. M., Parsons, A. D., Spitz, D. R., et al. (2012). Susceptibility of human head and neck cancer cells to combined inhibition of glutathione and thioredoxin metabolism. PLoS ONE 7:e48175. doi: 10.1371/journal.pone.0048175
214. Sobotta, M. C., Liou, W., Stöcker, S., Talwar, D., Oehler, M., Ruppert, T., et al. (2015). Peroxiredoxin-2 and STAT3 form a redox relay for H2O2 signaling. Nat. Chem. Biol. 11, 64-70. doi: 10.1038/nchembio.1695
215. Soini, Y., Kahlos, K., Näpänkangas, U., Kaarteenaho-Wiik, R., Säily, M., Koistinen, P., et al. (2001). Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma. Clin. Cancer Res. 7, 1750-1757
216. Stadtman, E. R., and Levine, R. L. (2003). Free radical-mediated oxidation of free amino acids and amino acid residues in proteins. Amino Acids 25, 207-218. doi: 10.1007/s00726-003-0011-2
217. Stanton, R. C., Seifter, J. L., Boxer, D. C., Zimmerman, E., and Cantley, L. C. (1991). Rapid release of bound glucose-6-phosphate dehydrogenase by growth factors correlation with increased enzymatic activity. J. Biol. Chem. 266, 12442-12448
218. Starheim, K. K., Holien, T., Misund, K., Johansson, I., Baranowska, K. A., Sponaas, A. M., et al. (2016). Intracellular glutathione determines bortezomib cytotoxicity in multiple myeloma cells. Blood Cancer J. 6, e446. doi: 10.1038/bcj.2016.56
219. Stresing, V., Baltziskueta, E., Rubio, N., Blanco, J., Arriba, M., Valls, J., et al. (2012). Peroxiredoxin 2 specifically regulates the oxidative and metabolic stress response of human metastatic breast cancer cells in lungs. Oncogene 32, 724-735. doi: 10.1038/onc.2012.93
220. Sukhatme, V. P., and Chan, B. (2012). Glycolytic cancer cells lacking 6-phosphogluconate dehydrogenase metabolize glucose to induce senescence. FEBS Lett. 586, 2389-2395. doi: 10.1016/j.febslet.2012.05.052
221. Sultana, R., Perluigi, M., and Butterfield, D. A. (2006). Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics. Antioxid. Redox Signal. 8, 2021-2037. doi: 10.1089/ars.2006.8.2021
222. Sun, Q. A., Kirnarsky, L., Sherman, S., and Gladyshev, V. N. (2001). Selenoprotein oxidoreductase with specificity for thioredoxin and glutathione systems. Proc. Natl. Acad. Sci. U.S.A. 98, 3673-3678. doi: 10.1073/pnas.051454398
223. Szatrowski, T. P., and Nathan, C. F. (1991). Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 51, 794-799
224. Tanaka, G., Inoue, K.-I., Shimizu, T., Akimoto, K., and Kubota, K. (2016). Dual pharmacological inhibition of glutathione and thioredoxin systems synergizes to kill colorectal carcinoma stem cells. Cancer Med. 5, 2544-2557. doi: 10.1002/cam4.844
225. Tedeschi, P. M., Markert, E. K., Gounder, M., Lin, H., Dvorzhinski, D., Dolfi, S. C., et al. (2013). Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells. Cell Death Dis. 4:e877. doi: 10.1038/cddis.2013.393
226. Thanan, R., Oikawa, S., Yongvanit, P., Hiraku, Y., Ma, N., Pinlaor, S., et al. (2012). Inflammation-induced protein carbonylation contributes to poor prognosis for cholangiocarcinoma. Free Radic. Biol. Med. 52, 1465-1472. doi: 10.1016/j.freeradbiomed.2012.01.018
227. Thomas, D. D., Ridnour, L. A., Espey, M. G., Donzelli, S., Ambs, S., Hussain, S. P., et al. (2006). Superoxide fluxes limit nitric oxide-induced signaling. J. Biol. Chem. 281, 25984-25993. doi: 10.1074/jbc. M602242200
228. Thomas, J. P., Maiorino, M., Ursini, F., and Girotti, A. W. (1990). Protective action of phospholipid hydroperoxide glutathione peroxidase against membrane-damaging lipid peroxidation: in situ reduction of phospholipid and cholesterol hydroperoxides. J. Biol. Chem. 265, 454-461
229. Thul, P. J., Åkesson, L., Wiking, M., Mahdessian, D., Geladaki, A., Ait Blal, H., et al. (2017). A subcellular map of the human proteome. Science 356:eaal3321. doi: 10.1126/science.aal3321
230. Tian, W. N., Pignatare, J. N., and Stanton, R. C. (1994). Signal transduction proteins that associate with the platelet-derived growth factor (PDGF) receptor mediate the PDGF-induced release of glucose-6-phosphate dehydrogenase from permeabilized cells. J. Biol. Chem. 269, 14798-14805
231. Tomalin, L. E., Day, A. M., Underwood, Z. E., Smith, G. R., Dalle Pezze, P., Rallis, C., et al. (2016). Increasing extracellular H2O2 produces a bi-phasic response in intracellular H2O2, with peroxiredoxin hyperoxidation only triggered once the cellular H2O2-buffering capacity is overwhelmed. Free Radic. Biol. Med. 95, 333-348. doi: 10.1016/j.freeradbiomed.2016.02.035
232. Tong, L., Chuang, C.-C., Wu, S., and Zuo, L. (2015). Reactive oxygen species in redox cancer therapy. Cancer Lett. 367, 18-25. doi: 10.1016/j.canlet.2015.07.008
233. Tong, W.-H., Rouault, T., Agar, J., Zheng, L., Cash, V., Dean, D., et al. (2000). Distinct iron-sulfur cluster assembly complexes exist in the cytosol and mitochondria of human cells. EMBO J. 19, 5692-5700. doi: 10.1093/emboj/19.21.5692
234. Torti, S. V., and Torti, F. M. (2013). Iron and cancer: more ore to be mined. Nat. Rev. Cancer 13, 342-355. doi: 10.1038/nrc3495
235. Toyokuni, S., Okamoto, K., Yodoi, J., and Hiai, H. (1995). Persistent oxidative stress in cancer. FEBS Lett. 358, 1-3. doi: 10.1016/0014-5793(94)01368-B
236. Trujillo, M., Clippe, A., Manta, B., Ferrer-Sueta, G., Smeets, A., Declercq, J. P., et al. (2007). Pre-steady state kinetic characterization of human peroxiredoxin 5: taking advantage of Trp84 fluorescence increase upon oxidation. Arch. Biochem. Biophys. 467, 95-106. doi: 10.1016/j.abb.2007.08.008
237. Tyson, J. J., Baumann, W. T., Chen, C., Verdugo, A., Tavassoly, I., Wang, Y., et al. (2011). Dynamic modelling of oestrogen signalling and cell fate in breast cancer cells. Nat. Rev. Cancer 11, 523-532. doi: 10.1038/nrc3081
238. Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., et al. (2015). Tissue-based map of the human proteome. Science 347, 1260419-1260419. doi: 10.1126/science.1260419
239. Uhlén, M., Hallstrom, B. M., Lindskog, C., Mardinoglu, A., Ponten, F., and Nielsen, J. (2016). Transcriptomics resources of human tissues and organs. Mol. Syst. Biol. 12, 862-862. doi: 10.15252/msb.20155865
240. Ushio-Fukai, M., and Nakamura, Y. (2008). Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett. 266, 37-52. doi: 10.1016/j.canlet.2008.02.044
241. Vander Heiden, M. G., Cantley, L. C., and Thompson, C. B. (2009). Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029-1034. doi: 10.1126/science.1160809
242. Van Remmen, H., Ikeno, Y., Hamilton, M., Pahlavani, M., Wolf, N., Thorpe, S. R., et al. (2003). Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol. Genomics 16, 29-37. doi: 10.1152/physiolgenomics.00122.2003
243. Väremo, L., Scheele, C., Broholm, C., Mardinoglu, A., Kampf, C., Asplund, A., et al. (2015). Proteome-and transcriptome-driven reconstruction of the human myocyte metabolic network and its use for identification of markers for diabetes. Cell Rep. 11, 921-933. doi: 10.1016/j.celrep.2015.04.010
244. Von Sonntag, C. (1987). The Chemical Basis of Radiation Biology. London, UK: Taylor and Francis
245. Wallace, M. A., Liou, L. L., Martins, J., Clement, M. H. S., Bailey, S., Longo, V. D., et al. (2004). Superoxide inhibits 4Fe-4S cluster enzymes involved in amino acid biosynthesis. Cross-compartment protection by CuZn-superoxide dismutase. J. Biol. Chem. 279, 32055-32062. doi: 10.1074/jbc. M403590200
246. Wang, C., Guo, K., Gao, D., Kang, X., Jiang, K., Li, Y., et al. (2011). Identification of transaldolase as a novel serum biomarker for hepatocellular carcinoma metastasis using xenografted mouse model and clinic samples. Cancer Lett. 313, 154-166. doi: 10.1016/j.canlet.2011.08.031
247. Wang, J., Yuan, W., Chen, Z., Wu, S., Chen, J., Ge, J., et al. (2012). Overexpression of G6PD is associated with poor clinical outcome in gastric cancer. Tumour Biol. 33, 95-101. doi: 10.1007/s13277-011-0251-9
248. Wang, T., Tamae, D., LeBon, T., Shively, J. E., Yen, Y., and Li, J. J. (2005). The role of peroxiredoxin II in radiation-resistant MCF-7 breast cancer cells. Cancer Res. 65, 10338-10346. doi: 10.1158/0008-5472.CAN-04-4614
249. Warburg, O. (1956). On the origin of cancer cells. Sci. New Ser. 123, 309-314. doi: 10.1126/science.123.3191.309
250. Wei, Q., Jiang, H., Xiao, Z., Baker, A., Young, M. R., Veenstra, T. D., et al. (2011). Sulfiredoxin-Peroxiredoxin IV axis promotes human lung cancer progression through modulation of specific phosphokinase signaling. Proc. Natl. Acad. Sci. U.S.A. 108, 7004-7009. doi: 10.1073/pnas.1013012108
251. Weidinger, A., and Kozlov, A. V. (2015). Biological Activities of reactive oxygen and nitrogen species: oxidative stress versus signal transduction. Biomolecules 5, 472-484. doi: 10.3390/biom5020472
252. Weinberg, F., Hamanaka, R., Wheaton, W. W., Weinberg, S., Joseph, J., Lopez, M., et al. (2010). Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc. Natl. Acad. Sci. U.S.A. 107, 8788-8793. doi: 10.1073/pnas.1003428107
253. Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., et al. (2013). The cancer genome atlas pan-cancer analysis project. Nat. Genet. 45, 1113-1120. doi: 10.1038/ng.2764
254. Wen, D., Liu, D., Tang, J., Dong, L., Liu, Y., Tao, Z., et al. (2015). Malic enzyme 1 induces epithelial-mesenchymal transition and indicates poor prognosis in hepatocellular carcinoma. Tumour Biol. 36, 6211-6221. doi: 10.1007/s13277-015-3306-5
255. Whitaker, H. C., Patel, D., Howat, W. J., Warren, A. Y., Kay, J. D., Sangan, T., et al. (2013). Peroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stress. Br. J. Cancer 109, 983-993. doi: 10.1038/bjc.2013.396
256. Winterbourn, C. C. (1995). Toxicity of iron and hydrogen peroxide: the Fenton reaction. Toxicol. Lett. 82-83, 969-974. doi: 10.1016/0378-4274(95)03532-X
257. Winterbourn, C. C. (2008). Reconciling the chemistry and biology of reactive oxygen species. Nat. Chem. Biol. 4, 278-286. doi: 10.1038/nchembio.85
258. Winterbourn, C. C. (2013). The biological chemistry of hydrogen peroxide. Meth. Enzymol. 528, 3-25. doi: 10.1016/B978-0-12-405881-1.00001-X
259. Winterbourn, C. C., and Metodiewa, D. (1999). Reactivity of biologically important thiol compounds with superoxide and hydrogen peroxide. Free Radic. Biol. Med. 27, 322-328. doi: 10.1016/S0891-5849(99)00051-9
260. Woo, H. A., Yim, S. H., Shin, D. H., Kang, D., Yu, D.-Y., and Rhee, S. G. (2010). Inactivation of peroxiredoxin I by phosphorylation allows localized H2O2 accumulation for cell signaling. Cell 140, 517-528. doi: 10.1016/j.cell.2010.01.009
261. Xu, I. M.-J., Lai, R. K.-H., Lin, S.-H., Tse, A. P.-W., Chiu, D. K.-C., Koh, H.-Y., et al. (2016). Transketolase counteracts oxidative stress to drive cancer development. Proc. Natl. Acad. Sci. USA. 113, E725-E734. doi: 10.1073/pnas.1508779113
262. Yizhak, K., Gaude, E., Le Dévédec, S., Waldman, Y. Y., Stein, G. Y., van de Water, B., et al. (2014a). Phenotype-based cell-specific metabolic modeling reveals metabolic liabilities of cancer. Elife 3:e03641. doi: 10.7554/eLife.03641
263. Yizhak, K., Le Dévédec, S. E., Rogkoti, V. M., Baenke, F., de Boer, V. C., Frezza, C., et al. (2014b). A computational study of the Warburg effect identifies metabolic targets inhibiting cancer migration. Mol. Syst. Biol. 10:744. doi: 10.15252/msb.20134993
264. Yoo, M. H., Xu, X. M., Carlson, B. A., Gladyshev, V. N., and Hatfield, D. L. (2006). Thioredoxin reductase 1 deficiency reverses tumor phenotype and tumorigenicity of lung carcinoma cells. J. Biol. Chem. 281, 13005-13008. doi: 10.1074/jbc. C600012200
265. Yu, H., Lee, H., Herrmann, A., Buettner, R., and Jove, R. (2014). Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nat. Rev. Cancer 14, 736-746. doi: 10.1038/nrc3818
266. Zack, T. I., Schumacher, S. E., Carter, S. L., Cherniack, A. D., Saksena, G., Tabak, B., et al. (2013). Pan-cancer patterns of somatic copy number alteration. Nat. Genet. 45, 1134-1140. doi: 10.1038/ng.2760
267. Zhan, L., Zhang, H., Zhang, Q., Woods, C. G., Chen, Y., Xue, P., et al. (2012). Regulatory role of KEAP1 and NRF2 in PPARγ expression and chemoresistance in human non-small-cell lung carcinoma cells. Free Radic. Biol. Med. 53, 758-768. doi: 10.1016/j.freeradbiomed.2012.05.041
268. Zhang, C., Lee, S., Mardinoglu, A., and Hua, Q. (2016). Investigating the combinatory effects of biological networks on gene co-expression. Front. Physiol. 7:160. doi: 10.3389/fphys.2016.00160
269. Zhang, C., Zhang, Z., Zhu, Y., and Qin, S. (2014). Glucose-6-phosphate dehydrogenase: a biomarker and potential therapeutic target for cancer. Anticancer. Agents Med. Chem. 14, 280-289. doi: 10.2174/18715206113136660337
270. Zhang, Q., Pi, J., Woods, C. G., and Andersen, M. E. (2010). A systems biology perspective on Nrf2-mediated antioxidant response. Toxicol. Appl. Pharmacol. 244, 84-97. doi: 10.1016/j.taap.2009.08.018
271. Zhao, Y., Xue, Y., Oberley, T. D., Hines, J., and Clair, D. S. (2001). Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model. Cancer Res. 61, 6082-6088
272. Zhong, H., and Yin, H. (2015). Role of lipid peroxidation derived 4-hydroxynonenal (4-HNE) in cancer: focusing on mitochondria. Redox Biol. 4, 193-199. doi: 10.1016/j.redox.2014.12.011
273. Zhou, J. P., Chen, X., Feng, S., Luo, S. D., Pan, Y. L., Zhong, L., et al. (2011). Systems biology modeling reveals a possible mechanism of the tumor cell death upon oncogene inactivation in egfr addicted cancers. PLoS ONE 6:e28930. doi: 10.1371/journal.pone.0028930